Min Wang1, Huai Zhang1,2, Dan Zhou1, Yong-Chao Qiao3, Yan-Hong Pan1, Yan-Chao Wang1, Hai-Lu Zhao4,5. 1. Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin, 541004, Guangxi, China. 2. School of Public Health, Guilin Medical University, Guilin, 541004, Guangxi, China. 3. Department of Immunology, School of Basic Medicine, Central South University, Changsha, 410078, Hunan, China. 4. Center for Diabetic Systems Medicine, Guangxi Key Laboratory of Excellence, Guilin Medical University, Guilin, 541004, Guangxi, China. zhaohailu9@126.com. 5. Department of Immunology, Guangxi Area of Excellence, Guilin Medical University, Huan Cheng North 2nd Road 109, Guilin, 541004, Guangxi, China. zhaohailu9@126.com.
Abstract
OBJECTIVE: Malignancy following renal transplantation remains inconsistent with the reported safety of kidney donation during the long-term follow-up. METHODS: We conducted searches of the published literature which included healthy participants, recipients, living kidney donors (LKDs), and the availability of outcome data for malignancy. Eight from 938 potentially relevant studies were analyzed by means of fixed-effects model or random-effects model, as appropriately. RESULTS: In 48,950 participants, the follow-up range was 18 months to 20 years, and the mean age of the subjects was approximately 41 years. The incidence rate with 95% confidence interval (CI) for malignancy after kidney transplantation was 0.03 (0.01-0.05) in recipients and 0.03 (0.1-0.07) in LKDs, giving a pooled incidence rate of 0.03 (95% CI 0.02-0.04). LKDs contrasted nondonors by the overall odds ratio and 95% CI for total cancer of 2.80 (2.69-2.92). CONCLUSIONS: Kidney transplantation was associated with an increased risk of cancer during a long-term follow-up. Long-term risk for cancer in LKDs and kidney recipients should be monitored.
OBJECTIVE:Malignancy following renal transplantation remains inconsistent with the reported safety of kidney donation during the long-term follow-up. METHODS: We conducted searches of the published literature which included healthy participants, recipients, living kidney donors (LKDs), and the availability of outcome data for malignancy. Eight from 938 potentially relevant studies were analyzed by means of fixed-effects model or random-effects model, as appropriately. RESULTS: In 48,950 participants, the follow-up range was 18 months to 20 years, and the mean age of the subjects was approximately 41 years. The incidence rate with 95% confidence interval (CI) for malignancy after kidney transplantation was 0.03 (0.01-0.05) in recipients and 0.03 (0.1-0.07) in LKDs, giving a pooled incidence rate of 0.03 (95% CI 0.02-0.04). LKDs contrasted nondonors by the overall odds ratio and 95% CI for total cancer of 2.80 (2.69-2.92). CONCLUSIONS: Kidney transplantation was associated with an increased risk of cancer during a long-term follow-up. Long-term risk for cancer in LKDs and kidney recipients should be monitored.
Entities:
Keywords:
Cancer; Kidney transplantation; Living kidney donors; Long-term outcomes; Recipients
Authors: Jesse D Schold; David A Goldfarb; Laura D Buccini; James R Rodrigue; Didier Mandelbrot; Emily L G Heaphy; Richard A Fatica; Emilio D Poggio Journal: Clin J Am Soc Nephrol Date: 2014-01-23 Impact factor: 8.237
Authors: Dorry L Segev; Abimereki D Muzaale; Brian S Caffo; Shruti H Mehta; Andrew L Singer; Sarah E Taranto; Maureen A McBride; Robert A Montgomery Journal: JAMA Date: 2010-03-10 Impact factor: 56.272
Authors: Hai-Lu Zhao; Yi Sui; Jing Guan; Lan He; Xun Zhu; Rong-Rong Fan; Gang Xu; Alice P S Kong; Chung Shun Ho; Fernand M M Lai; Dewi K Rowlands; Juliana C N Chan; Peter C Y Tong Journal: Kidney Int Date: 2008-05-21 Impact factor: 10.612